|
1
|
Lee JL, Park SI, Kim SB, et al: A single
institutional phase III trial of preoperative chemotherapy with
hyperfractionation radiotherapy plus surgery versus surgery alone
for resectable esophageal squamous cell carcinoma. Ann Oncol.
15:947–954. 2004. View Article : Google Scholar
|
|
2
|
Choi JY, Jang HJ, Shim YM, et al:
18F-FDG PET in patients with esophageal squamous cell
carcinoma undergoing curative surgery: prognostic implications. J
Nucl Med. 45:1843–1850. 2004.
|
|
3
|
Yuequan J, Shifeng C and Bing Z:
Prognostic factors and family history for survival of esophageal
squamous cell carcinoma patients after surgery. Ann Thorac Surg.
90:908–913. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Flamen P, Lerut A, Van Cutsem E, et al:
Utility of positron emission tomography for the staging of patients
with potentially operable esophageal carcinoma. J Clin Oncol.
18:3202–3210. 2000.PubMed/NCBI
|
|
5
|
Kato H, Miyazaki T, Nakajima M, et al: The
incremental effect of positron emission tomography on diagnostic
accuracy in the initial staging of esophageal carcinoma. Cancer.
103:148–156. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thurau K, Palmes D, Franzius C, Minin E,
Senninger N, Juergens KU and Bruewer M: Impact of PET-CT on primary
staging and response control on multimodal treatment of esophageal
cancer. World J Surg. 35:608–616. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang ZJ, Chen JH, Meng L, Du JJ, Zhang L,
Liu Y and Dai HH: 18F-FDG uptake as a biologic factor
predicting outcome in patients with resected non-small-cell lung
cancer. Chin Med J (Engl). 120:125–131. 2007.
|
|
8
|
Vesselle H, Schmidt RA, Pugsley JM, Li M,
Kohlmyer SG, Vallires E and Wood DE: Lung cancer proliferation
correlates with [F-18]fluorodeoxyglucose uptake by positron
emission tomography. Clin Cancer Res. 6:3837–3844. 2000.
|
|
9
|
Sepesi B, Raymond DP, Polomsky M, et al:
Does the value of PET-CT extend beyond pretreatment staging? An
analysis of survival in surgical patients with esophageal cancer. J
Gastrointest Surg. 13:2121–2127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhong X, Yu J, Zhang B, et al: Using
18F-fluorodeoxyglucose positron emission tomography to
estimate the length of gross tumor in patients with squamous cell
carcinoma of the esophagus. Int J Radiat Oncol Biol Phys.
73:136–141. 2009.
|
|
11
|
Suzuki A, Xiao L, Hayashi Y, et al:
Prognostic significance of baseline positron emission tomography
and importance of clinical complete response in patients with
esophageal or gastroesophageal junction cancer treated with
definitive chemoradiotherapy. Cancer. 117:4823–4833. 2011.
View Article : Google Scholar
|
|
12
|
Feng R, Li MH, Kong L, Shi F, Yang GR and
Yu JM: Correlation between PET-CT 18FDG uptake in
primary lesions and clinicopathological parameters in esophageal
carcinoma patients. Zhonghua Zhong Liu Za Zhi. 31:452–454. 2009.(In
Chinese).
|
|
13
|
Mu DB, Wang SP, Yang WF, Fu Z, Chen XX,
Sun XR and Yu JM: Correlation between FDG PET/CT and the expression
of glutl and ki-67 antigen in esophageal cancer. Zhonghua Zhong Liu
Za Zhi. 29:30–33. 2007.(In Chinese).
|
|
14
|
Cerfolio RJ and Bryant AS: Maximum
standardized uptake values on positron emission tomography of
esophageal cancer predicts stage, tumor biology, and survival. Ann
Thorac Surg. 82:391–394. 2006. View Article : Google Scholar
|
|
15
|
Greene FL, Page DL, Fleming ID, et al:
AJCC Cancer Staging Manual. 6th edition. Springer; New York, NY:
2002, View Article : Google Scholar
|
|
16
|
Kato H, Kuwano H, Nakajima M, et al:
Comparison between positron emission tomography and computed
tomography in the use of the assessment of esophageal carcinoma.
Cancer. 94:921–928. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Buchmann I, Haberkorn U, Schmidtmann I,
Brochhausen C, Buchholz HG, Bartenstein P and Hansen T: Influence
of cell proportions and proliferation rates on FDG uptake in
squamous-cell esophageal carcinoma: a PET study. Cancer Biother
Radiopharm. 23:172–180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kato H, Nakajima M, Sohda M, et al: The
clinical application of (18)F-fluorodeoxyglucose positron emission
tomography to predict survival in patients with operable esophageal
cancer. Cancer. 15:3196–3203. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Pan YD, Yin JL and Li XD: Analysis
of standard uptake values of 18F-FDG PET/CT in relation
to pathological classification and clinical staging of
nasopharyngeal carcinoma. Nan Fang Yi Ke Da Xue Xue Bao.
28:1923–1924. 2008.(In Chinese).
|
|
20
|
Hsu WH, Hsu PK, Wang SJ, Lin KH, Huang CS,
Hsieh CC and Wu YC: Positron emission tomography-computed
tomography in predicting locoregional invasion in esophageal
squamous cell carcinoma. Ann Thorac Surg. 87:1564–1568. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li M, Sun Y, Liu Y, et al: Relationship
between primary lesion FDG uptake and clinical stage at PET-CT for
non-small cell lung cancer patients: an observation. Lung Cancer.
68:394–397. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rizk N, Downey RJ, Akhurst T, Gonen M,
Bains MS, Larson S and Rusch V: Preoperative
18[F]-fluorodeoxyglucose positron emission tomography
standardized uptake values predict survival after esophageal
adenocarcinoma resection. Ann Thorac Surg. 81:1076–1081. 2006.
|
|
23
|
van Westreenen HL, Plukker JT, Cobben DC,
Verhoogt CJ, Groen H and Jager PL: Prognostic value of the
standardized uptake value in esophageal cancer. AJR Am J
Roentgenol. 185:436–40. 2005.PubMed/NCBI
|
|
24
|
Liu H, Lu L, Zhu Q, et al: Cervical nodal
metastases of unresectable thoracic esophageal squamous cell
carcinoma: characteristics of long-term survivors after concurrent
chemoradiotherapy. Radiother Oncol. 99:181–186. 2011. View Article : Google Scholar
|
|
25
|
Eloubeidi MA, Desmond R, Arguedas MR, Reed
CE and Wilcox CM: Prognostic factors for the survival of patients
with esophageal carcinoma in the U.S.: the importance of tumor
length and lymph node status. Cancer. 95:1434–1443. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Roedl JB, Sahani DV, Colen RR, Fischman
AJ, Mueller PR and Blake MA: Tumour length measured on PET-CT
predicts the most appropriate stage-dependent therapeutic approach
in oesophageal cancer. Eur Radiol. 18:2833–2840. 2008. View Article : Google Scholar : PubMed/NCBI
|
